Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2020-08-13 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchanges about an upcoming Board Meeting scheduled to consider the unaudited financial results for the quarter ended June 30, 2020, and to approve the notice of the 32nd Annual General Meeting. It is an announcement of a meeting and not the financial results report itself. The document is short (1618 characters) and serves as an intimation rather than containing substantive financial data or analysis. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and upcoming financial results consideration, not the actual Interim/Quarterly Report or Annual Report.
2020-08-13 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter from Alpa Laboratories Ltd. addressed to stock exchanges (BSE and NSE) clarifying that there is no price sensitive information or event that would impact the company's performance or stock price. It explicitly states that no such announcement is forthcoming. The document is short (1639 characters) and serves as a regulatory clarification or statement rather than a financial report or announcement of results. There is no financial data, no mention of a report being attached or published, and no indication of management changes, dividends, or other specific filings. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement or compliance document that does not fit other categories.
2020-08-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (257 characters) and contains only stock exchange names, addresses, and scrip codes without any substantive content, financial data, or report details. There is no indication of a report, announcement, or detailed filing. Given the lack of content and the nature of the text, it is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous or minimal filings that do not fit other categories.
2020-07-04 English
Related Party Transactions
Remuneration Information Classification · 85% confidence The document contains tabular data related to remuneration of Key Managerial Personnel (KMP), relatives, sitting fees to independent directors, and investments in current accounts. This type of information is typically found in reports detailing compensation and related party transactions. The document length is very short (469 characters), and it appears to be a snippet or summary rather than a full report. Given the focus on remuneration and related party transactions, the most appropriate classification is Remuneration Information (DEF 14A).
2020-07-03 English
Financial Result Updates
Regulatory Filings
2020-06-30 English
Outcome of Board Meeting
Regulatory Filings
2020-06-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.